Management of high-risk gestational trophoblastic disease - The Memorial Hospital experience
- 1 January 1997
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 7 (1) , 27-33
- https://doi.org/10.1046/j.1525-1438.1997.00409.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- EMACO in High Risk Gestational Trophoblast Disease ‐ The Australian ExperienceAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1994
- Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989BJOG: An International Journal of Obstetrics and Gynaecology, 1991
- EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT)Gynecologic Oncology, 1988
- Modified Triple ChemotherapyPublished by Springer Nature ,1987
- Choriocarcinoma associated with term gestationAmerican Journal of Obstetrics and Gynecology, 1984
- Risk and prognostic factors in trophoblastic neoplasiaCancer, 1976
- Monitor of chemotherapy in gestational trophoblastic neoplasm by radioimmunoassay of the β-subunit of human chorionic gonadotropinAmerican Journal of Obstetrics and Gynecology, 1975
- Treatment of metastatic trophoblastic disease: Good and poor prognosisAmerican Journal of Obstetrics and Gynecology, 1973
- Sequential use of methotrexate and actinomycin D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in womenAmerican Journal of Obstetrics and Gynecology, 1965
- Five years' experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in womenAmerican Journal of Obstetrics and Gynecology, 1961